NM_001025389.1(AMPD3):c.-239G>C AND Erythrocyte AMP deaminase deficiency
- Germline classification:
- Benign (1 submission)
- Last evaluated:
- Jan 12, 2018
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000360916.14
Allele description [Variation Report for NM_001025389.1(AMPD3):c.-239G>C]
NM_001025389.1(AMPD3):c.-239G>C
Condition(s)
Assertion and evidence details
Last Updated: Feb 1, 2025